Abdallah M. Ibrahim: Evolving Hemophilia Care – How Do We Choose the Right Biomarkers?
Abdallah M. Ibrahim, Senior Medical Student at Alexandria University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in ASIDE, adding:
“Glad to share another research publication that our narrative review, ‘Biomarkers in Hemophilia: Diagnostic, Prognostic, and Treatment-Selection Utility,’ has been published in American Society for Inclusion, Diversity, and Equity in Healthcare (ASIDE) Internal medicine (Vol. 2, No. 5, 2026).
Hemophilia care is evolving fast:
Extended half-life therapies, non-factor treatments, and gene therapy are changing what’s possible, but that progress raises a real question: how do we select the right biomarkers to guide diagnosis, risk stratification, and treatment choice?
Our review synthesized the literature from 2000 to 2025, covering established tools (FVIII/FIX activity assays, inhibitor testing, genotyping, imaging-based joint assessment) alongside emerging candidates like global hemostasis assays and inflammatory biomarkers linked to joint disease.
The conclusion is honest: evidence in this space is still heterogeneous, and most non-traditional markers remain exploratory pending standardized, multicenter validation.”
Title: Biomarkers in Hemophilia: Diagnostic, Prognostic, and Treatment-Selection Utility: A Narrative Review of the Literature
Authors: Dalia Atef Abouda, Elsayed S. Moubarak, Fatma ElBadrawy, Malak A. Hassan, Mohamed Mohsen Helal, Abdallah M. Ibrahim, Hassan H. Eladl, Mohammad Mahadin, Mohamed Elsaid
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 12:21Jalen Hurts Sidelined by a Superficial Blood Clot: What to Know
-
Oct 17, 2026, 09:33Robert Lookstein: Mechanical Thrombectomy Shows Functional Benefits in Intermediate-High-Risk PE
-
Oct 17, 2026, 09:18Sarra Hmidi: Tunisia Highlights Thrombosis Prevention on World Thrombosis Day
-
Oct 17, 2026, 09:05Addressing the Hidden Burden of Bleeding Disorders in Women – Hemophilia Society Mumbai Chapter
-
Oct 17, 2026, 08:49Maria Magnusson: Karolinska Experts Explore Gene Therapy in Sickle Cell Disease and Hemophilia
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries